id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-343739-t3z6ghyp	Conforti, Claudio	Management of advanced melanoma in the COVID‐19 era	2020-05-14		.txt	text/plain	221	26	56	key: cord-343739-t3z6ghyp cord_uid: t3z6ghyp For patients undergoing treatment with immunosuppressive or immunomodulating drugs for chronic dermatological diseases, such as psoriasis, several guidelines suggest to assess on a case-by-case basis the initiation of a new therapy with a biological drug as well as the possible suspension in case of positivity. 2 Apart from psoriasis, which can sometimes also be treated in an alternative way, we must focus our attention on the most fragile patients in dermatology, that is, oncologic patients suffering from advanced melanoma. In fact, we should remember that cancer-related treatments may cause immunosuppression, and the first available data suggest that patients with cancer have a risk of excess mortality due to SARS-CoV-2. Coronavirus disease 2019 (COVID-19): facts and controversies COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? Oncology practice during the COVID-19 pandemic AIOM, Rischio infettivo da Coronavirus Covid-19: indicazioni per l'oncologia Cancer patient management during the covid-19 pandemic	./cache/cord-343739-t3z6ghyp.txt	./txt/cord-343739-t3z6ghyp.txt